NorthX Innovation Hub
In 2021 the Swedish Innovation Agency together with the Swedish Government recognized and awarded NorthX to become an international Innovation hub for Advance Biologics and Advanced Therapy Medicinal Products (ATMPs). Our goal is to accelerate client projects and move them forward in clinical process through open collaboration in process and analytical development, connections with financiers (public or private) and further production for clinical or commercial product. The Innovation Hub also serves an important role in competence and capacity development of seamless transfer of projects between different clinical stages and quality levels.
Innovation through Infrastructure
Leveraging our expertise and infrastructure, we accelerate your journey to clinical success and collaborate closely to overcome obstacles. Get in touch with us to learn more about the NorthX Innovation Hub.
NorthX Biologics - A recognised Innovation Hub
NorthX boasts a dedicated and knowledgeable team in CMC and process development and state-of-the-art equipment, supporting your project across early development and clinical production. Our focus is in pre-clinical and early clinical stages and offer services in the following areas:
- Process and Analytical Development for both microbial and mammalian expression systems.
- Development and Characterization of Master Cell Banks (MCB) and Working Cell (WCB).
- Development and Characterization.
- Manufacturing of Proteins, Enzymes, and antibodies.
- Manufacturing Plasmid DNA.
- Manufacturing of virus and Viral Vector (up to BSL 3).
- Viral Master Seed Banks (MSB) and Working Seed Banks (WSB).
- Non-Viral Vector Development and Manufacturing
Need for Innovation
We recognize that there may be projects that need more than just a service provider, and we provide that through our Innovation Track. We are a different kind of biologics company, because we are in it for the long term, adapting our GMP-manufacturing expertise to the changing technological landscape. Being recognised by the Swedish Government as an Innovation Hub is a testament to this. We are serious about helping you to bring advanced medicines to patients !
Current collaborations
NorthX Biologics is currently collaborating as part of the OpenCorona Project led by the Karolinska Institute in Sweden. In this collaboration, NorthX Biologics is responsible for the production of non-GMP and GMP Plasmids to support the development and commercialization of a DNA-vaccine for Covid-19.
Enter text here...
Any questions?
Please do not hesitate to ask for more information. We will be happy to answer.